Share on LinkedInShare on LinkedIn

ARTICLE · 18 AUGUST 2022

The Bolar Exemption And Data Exclusivity: How They Apply In Turkey

Moroglu Arseven
Moroglu Arseven
Contributor
Moroglu Arseven

Moroglu Arseven

Celebrating its 25th year, Moroğlu Arseven is an independent, full-service Turkish law firm...

View firm profile
Explore more from Moroglu Arseven

In Turkey, pharmaceutical products for human use cannot be marketed unless they are authorized by the Ministry of Health ("MoH"). In order to grant pharmaceutical license and marketing authorization...

TurkeyIntellectual Property

In Turkey, pharmaceutical products for human use cannot be marketed unless they are authorized by the Ministry of Health (“MoH”). In order to grant pharmaceutical license andh marketing authorization, MoH requires pharmaceutical companies to submit the results of their pharmaceuticals' safety and efficacy tests, along with other documents regarding the product.

In effect, pharmaceutical companies must invent and develop a pharmaceutical product through intensive and time-consuming research and development activities, then provide the results of the toxicological and pharmacological tests and clinical trials to MoH in order to commercially exploit their product. This is a long and costly process for introducing new or more effective treatments for patients.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from